Citation Impact
Citing Papers
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
1984
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
1989 Standout
Platelets as inflammatory cells
1989
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Ketotifen
1990
Is Asymptomatic Bronchial Hyperresponsiveness an Indication of Potential Asthma?
1992
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
The role of platelets in the pathophysiology of asthma
2007
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The development of allergic inflammation
2008 StandoutNature
Features and uses of high-fidelity medical simulations that lead to effective learning: a BEME systematic review
2005 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Adenosine 5??-Triphosphate Axis in Obstructive Airway Diseases
2002
Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, a novel acyl-CoA synthetase inhibitor
1992 StandoutNobel
Long-term Oxygen Therapy at Home
1996
Platelet Activation During Allergic Inflammation
2007
The Pleura
1988 Standout
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 Standout
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Platelet-activating factor as a mediator of allergic disease
1988
Asthma
2000 Standout
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Development and Validation of the Medication Regimen Complexity Index
2004 Standout
Efficacy of Resident Training in Smoking Cessation
2002
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Pulmonary aspergillus infection invading the pleura.
1981
Infection of the pleura by Aspergillus fumigatus
1970
Mycoinsecticides and Mycoacaricides: A comprehensive list with worldwide coverage and international classification of formulation types
2007 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Anticholinergic therapy for chronic asthma in children over two years of age
2003
Human Deep Tissue Infection with an EntomopathogenicBeauveriaSpecies
2002
Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples.
1997
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin-Based Treatment: An Analytical Review
2003
Teaching Smoking-Cessation Counseling to Medical Students Using Simulated Patients
1997
Works of P Fréour being referenced
Prevention of exercise-induced asthma by oxitropium bromide
1987
Medical education on tobacco: implications of a worldwide survey
1994
Platelet Kinetics in Stable Atopic Asthmatic Patients 1, 2
1986
[Bronchial hyper-reactivity].
1984
[Long-term results of a trial of short-term chemotherapy. French study 6.9.12].
1983
[On a voluminous intra-pleural aspergilloma].
1998
Definition of Asthma
1987
Compliance of COPD patients with long term oxygen therapy.
1986
["Beauveria" fungi in human pathology. Apropos of a case of pulmonary localization].
1966